This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Clinical Supply Chain Remove Drugs Remove Genetics Related Topics
Clinical Supply Pharma Companies In-Vivo Regulation Clinical Trials Containment Gene Therapy Medicine Trials Life Science More Related Topics >
article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

MAY 24, 2023

By Luisa Sterkel & Joana Loureiro , Tenthpin Consultants The promise and potential of cell and gene therapies (CGT) has emerged in the recent past and currently over 1.500 CGT are registered for clinical trials holding great hope for the treatment of challenging and uncurable diseases.

Clinical Trials 246
Clinical Trials Clinical Trials Gene Therapy Clinical Supply Chain 246
article thumbnail

Africa: Unleashing the potential of the new superpower in clinical trials

Pharmaceutical Technology

MARCH 20, 2023

These high rates of diseases in largely untapped patient pools, present invaluable opportunities to trial new drugs that can help people living with chronic conditions and battling serious illnesses. However, Africa currently accounts for a very low percentage of global clinical trials, with estimates putting it at approximately 2.5%.

Clinical Trials 130
Clinical Trials Clinical Trials Trials Clinical Supply Chain 130
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024